GEO observational study: 24 months characteristics of socioeconomic and clinical status in schizophrenia patients treated with olanzapine and haloperidol in Germany

被引：0
|
作者：
Eichmann, F
Reitberger, U
Clouth, J
Czekalla, J
机构：
[1] Kendle GmbH & Co GMI KG, Munich, Germany
[2] Lilly Deutschland GmbH, Bad Homburg, Germany
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67770-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A203 / A203
页数：1
相关论文
共 50 条
  • [41] Clinical and functional response to paliperidone palmitate in early schizophrenia-A retrospective observational study in newly diagnosed patients treated over a 12-month period
    Hargarter, L.
    Bergmans, P.
    Cherubin, P.
    Schreiner, A.
    EUROPEAN PSYCHIATRY, 2016, 33 : S250 - S251
  • [42] CLINICAL EFFECTIVENESS AND SAFETY OF ADALIMUMAB VERSUS NON-BIOLOGIC THERAPY IN PSORIATIC ARTHRITIS PATIENTS OVER 24 MONTHS - RESULTS OF THE COMPLETE-PsA CANADIAN OBSERVATIONAL STUDY
    Khraishi, M.
    Stewart, J.
    Setty, Y.
    Laliberte, M. C.
    Bessette, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1314 - 1315
  • [43]  A global, observational, cohort study of patients with atopic dermatitis to evaluate tralokinumab real-world clinical use (TRACE): baseline characteristics from the first 100 patients in Germany
    Thaci, Diamant
    Kleinheinz, Andreas
    Anastasiadou, Dimitra Maria
    Stinson, John
    Armstrong, April W.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [44] Demography, clinical characteristics and socioeconomic status of the Portuguese patients with multiple sclerosis in 2014-results of the national cross-sectional PORT-MS study
    Tomas, J.
    Ferreira, J. Dias
    Sequeira, J.
    Grilo, M.
    Samoes, R.
    Varanda, S.
    Morgado, J.
    Guimaraes, J.
    Nunes, C.
    Cerqueira, J. J. F. C. A.
    Vale Santos, J. M.
    Sa, M. J.
    Silva, A. A. D. M.
    Sousa, L. M. A. F. D.
    Pedrosa, R. M. G.
    de Sa, J.
    Alegria, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 395 - 395
  • [45] Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
    Sass, Marie Reeberg
    Danielsen, Andreas Aalkjaer
    Kohler-Forsberg, Ole
    Storgaard, Heidi
    Knop, Filip K.
    Nielsen, Mette Odegaard
    Sjodin, Anders Mikael
    Mors, Ole
    Correll, Christoph U.
    Ekstrom, Claus
    Vinberg, Maj
    Nielsen, Jimmi
    Vilsboll, Tina
    Fink-Jensen, Anders
    BMJ OPEN, 2023, 13 (01):
  • [46] CLINICAL AND RADIOLOGICAL MANIFESTATIONS OF COXITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) TREATED WITH TNF-ALPHA INHIBITOR GOLIMUMAB: RESULTS OF A 24-MONTHS OBSERVATION (GO-COX STUDY)
    Erdes, S.
    Agafonova, E.
    Rumiantceva, D.
    Davidian, S.
    Zemerova, E.
    Kulikov, A.
    Markova, O.
    Lukyanova, E.
    Achikyan, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 709 - 710
  • [47] Prognostic factors associated with pulp status in patients with cracked teeth treated with occlusal veneer A 6-through 24-month prospective clinical study
    Pu, Yinfei
    Wang, Mengke
    Hong, Yingying
    Bai, Jie
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2024, 155 (05): : 390 - 398.e2
  • [48] Clinical characteristics and survival outcomes in patients aged 75 years or older with advanced colorectal cancer treated using traditional Chinese medicine: an observational retrospective study
    Wu, Jiao
    Cui, Ning
    Li, Zhongyu
    Wu, Yu
    Hao, Tengteng
    Li, Liusheng
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [49] A multicenter, retrospective observational study investigating baseline characteristics and clinical outcomes in patients with hormone-sensitive prostate cancer treated with primary androgen deprivation therapy
    Taguchi, Satoru
    Onozawa, Mizuki
    Hinotsu, Shiro
    Kawai, Taketo
    Mitomi, Takeshi
    Uno, Satoshi
    Kume, Haruki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (10) : 957 - 965
  • [50] Clinical Effectiveness and Safety of Cladribine Tablets for Patients Treated at least 24 Months in the Swedish post-market surveillance study "Immunomodulation and Multiple Sclerosis Epidemiology 10" (IMSE 10)
    Larsson, Veronica
    Forsberg, Linda
    Hillert, Jan
    Nilsson, Petra
    Dahle, Charlotte
    Svenningsson, Anders
    Lycke, Jan
    Landtblom, Anne-Marie
    Burman, Joachim
    Martin, Claes
    Sundstrom, Peter
    Gunnarsson, Martin
    Piehl, Fredrik
    Olsson, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 665 - 666
12345